These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 22289725)
21. Short-acting β-agonist use and its ability to predict future asthma-related outcomes. Stanford RH; Shah MB; D'Souza AO; Dhamane AD; Schatz M Ann Allergy Asthma Immunol; 2012 Dec; 109(6):403-7. PubMed ID: 23176877 [TBL] [Abstract][Full Text] [Related]
22. Cross-sectional analysis of the relationship between national guideline recommended asthma drug therapy and emergency/hospital use within a managed care population. Nestor A; Calhoun AC; Dickson M; Kalik CA Ann Allergy Asthma Immunol; 1998 Oct; 81(4):327-30. PubMed ID: 9809496 [TBL] [Abstract][Full Text] [Related]
23. Design and baseline characteristics of the epidemiology and natural history of asthma: Outcomes and Treatment Regimens (TENOR) study: a large cohort of patients with severe or difficult-to-treat asthma. Dolan CM; Fraher KE; Bleecker ER; Borish L; Chipps B; Hayden ML; Weiss S; Zheng B; Johnson C; Wenzel S; Ann Allergy Asthma Immunol; 2004 Jan; 92(1):32-9. PubMed ID: 14756462 [TBL] [Abstract][Full Text] [Related]
24. Forced expiratory volume in 1 second percentage improves the classification of severity among children with asthma. Fuhlbrigge AL; Weiss ST; Kuntz KM; Paltiel AD; Pediatrics; 2006 Aug; 118(2):e347-55. PubMed ID: 16864642 [TBL] [Abstract][Full Text] [Related]
25. Associations between fluctuations in lung function and asthma control in two populations with differing asthma severity. Thamrin C; Nydegger R; Stern G; Chanez P; Wenzel SE; Watt RA; FitzPatrick S; Taylor DR; Frey U Thorax; 2011 Dec; 66(12):1036-42. PubMed ID: 21602542 [TBL] [Abstract][Full Text] [Related]
26. Uncontrolled asthma among children: impairment in social functioning and sleep. Dean BB; Calimlim BC; Sacco P; Aguilar D; Maykut R; Tinkelman D J Asthma; 2010 Jun; 47(5):539-44. PubMed ID: 20536279 [TBL] [Abstract][Full Text] [Related]
27. Effect of long-acting beta2 agonists on exacerbation rates of asthma in children. Bisgaard H Pediatr Pulmonol; 2003 Nov; 36(5):391-8. PubMed ID: 14520721 [TBL] [Abstract][Full Text] [Related]
28. Recent asthma exacerbations predict future exacerbations in children with severe or difficult-to-treat asthma. Haselkorn T; Zeiger RS; Chipps BE; Mink DR; Szefler SJ; Simons FE; Massanari M; Fish JE J Allergy Clin Immunol; 2009 Nov; 124(5):921-7. PubMed ID: 19895984 [TBL] [Abstract][Full Text] [Related]
29. Potential predictors of relapse after treatment of asthma exacerbations in children. Topal E; Gücenmez OA; Harmancı K; Arga M; Derinoz O; Turktas I Ann Allergy Asthma Immunol; 2014 Apr; 112(4):361-4. PubMed ID: 24583137 [TBL] [Abstract][Full Text] [Related]
30. Cardiovascular disease risk associated with asthma and respiratory morbidity might be mediated by short-acting beta2-agonists. Appleton SL; Ruffin RE; Wilson DH; Taylor AW; Adams RJ; J Allergy Clin Immunol; 2009 Jan; 123(1):124-130.e1. PubMed ID: 19130933 [TBL] [Abstract][Full Text] [Related]
31. Treatment with inhaled mometasone furoate reduces short-acting β(2) agonist claims and increases adherence compared to fluticasone propionate in asthma patients. Navaratnam P; Friedman HS; Urdaneta E Value Health; 2011; 14(2):339-46. PubMed ID: 21402302 [TBL] [Abstract][Full Text] [Related]
32. Effectiveness of omalizumab in patients with inadequately controlled severe persistent allergic asthma: an open-label study. Niven R; Chung KF; Panahloo Z; Blogg M; Ayre G Respir Med; 2008 Oct; 102(10):1371-8. PubMed ID: 18657960 [TBL] [Abstract][Full Text] [Related]
33. Identifying an at-risk population of children with recurrent near-fatal asthma exacerbations. Carroll CL; Uygungil B; Zucker AR; Schramm CM J Asthma; 2010 May; 47(4):460-4. PubMed ID: 20528602 [TBL] [Abstract][Full Text] [Related]
34. Subacute lack of asthma control as a predictor of subsequent acute asthma exacerbation in a managed care population. Stephenson JJ; Quimbo RA; Gutierrez B Am J Manag Care; 2010 Feb; 16(2):108-14. PubMed ID: 20148615 [TBL] [Abstract][Full Text] [Related]
35. Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007. National Asthma Education and Prevention Program J Allergy Clin Immunol; 2007 Nov; 120(5 Suppl):S94-138. PubMed ID: 17983880 [TBL] [Abstract][Full Text] [Related]
36. Does pre-hospital telephone communication with a clinician result in more appropriate medication administration by parents during childhood asthma exacerbations? Garro AC; Fearon D; Koinis-Mitchell D; McQuaid EL J Asthma; 2009 Nov; 46(9):916-20. PubMed ID: 19905918 [TBL] [Abstract][Full Text] [Related]
37. Key findings and clinical implications from The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study. Chipps BE; Zeiger RS; Borish L; Wenzel SE; Yegin A; Hayden ML; Miller DP; Bleecker ER; Simons FE; Szefler SJ; Weiss ST; Haselkorn T; J Allergy Clin Immunol; 2012 Aug; 130(2):332-42.e10. PubMed ID: 22694932 [TBL] [Abstract][Full Text] [Related]
38. Effect of clarithromycin on acute asthma exacerbations in children: an open randomized study. Koutsoubari I; Papaevangelou V; Konstantinou GN; Makrinioti H; Xepapadaki P; Kafetzis D; Papadopoulos NG Pediatr Allergy Immunol; 2012 Jun; 23(4):385-90. PubMed ID: 22433020 [TBL] [Abstract][Full Text] [Related]
39. Real-time asthma outreach reduces excessive short-acting β2-agonist use: a randomized study. Zeiger RS; Schatz M; Li Q; Solari PG; Zazzali JL; Chen W J Allergy Clin Immunol Pract; 2014; 2(4):445-456, 456.e1-5. PubMed ID: 25017534 [TBL] [Abstract][Full Text] [Related]
40. A guideline-based approach to asthma management. Jones CC; Becker EA; Catrambone CD; Martin MA Nurs Clin North Am; 2013 Mar; 48(1):35-45. PubMed ID: 23465445 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]